Hatlebakk JG - Search Results

1

Is irritable bowel syndrome an organic disorder?

El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG, Hausken T. El-Salhy M, et al. Among authors: hatlebakk jg. World J Gastroenterol. 2014 Jan 14;20(2):384-400. doi: 10.3748/wjg.v20.i2.384. World J Gastroenterol. 2014. PMID: 24574708 Free PMC article. Review.

2

Spiramycin in triple therapy of Helicobacter pylori-associated peptic ulcer disease. An open pilot study with 12-month follow-up.

Berstad A, Berstad K, Wilhelmsen I, Hatlebakk JG, Nesje LB, Hausken T. Berstad A, et al. Among authors: hatlebakk jg. Aliment Pharmacol Ther. 1995 Apr;9(2):197-200. doi: 10.1111/j.1365-2036.1995.tb00371.x. Aliment Pharmacol Ther. 1995. PMID: 7605862 Clinical Trial.

3

Lansoprazole capsules and amoxicillin oral suspension in the treatment of peptic ulcer disease.

Hatlebakk JG, Nesje LB, Hausken T, Bang CJ, Berstad A. Hatlebakk JG, et al. Scand J Gastroenterol. 1995 Nov;30(11):1053-7. doi: 10.3109/00365529509101606. Scand J Gastroenterol. 1995. PMID: 8578163 Clinical Trial.

4

Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).

Tefera S, Berstad A, Bang CJ, Nysaeter G, Hatlebakk JG, Olafsson S, Nesje LB, Hausken T, Berstad K, Hundal O. Tefera S, et al. Among authors: hatlebakk jg. Am J Gastroenterol. 1996 May;91(5):935-41. Am J Gastroenterol. 1996. PMID: 8633584 Clinical Trial.

5

Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection.

Berstad A, Hatlebakk JG, Wilhelmsen I, Berstad K, Bang CJ, Nysaeter G, Hausken T, Weberg R, Nesje LB, Hjartholm AS. Berstad A, et al. Among authors: hatlebakk jg. Hepatogastroenterology. 1995 Sep-Oct;42(5):655-9. Hepatogastroenterology. 1995. PMID: 8751230

6

Spiramycin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazole.

Olafsson S, Berstad A, Bang CJ, Nysaeter G, Coll P, Tefera S, Hatlebakk JG, Hausken T, Olafsson T. Olafsson S, et al. Among authors: hatlebakk jg. Aliment Pharmacol Ther. 1999 May;13(5):651-9. doi: 10.1046/j.1365-2036.1999.00517.x. Aliment Pharmacol Ther. 1999. PMID: 10233189 Free article. Clinical Trial.

7

Gastric accommodation studied by ultrasonography in patients with reflux esophagitis.

Tefera S, Gilja OH, Hatlebakk JG, Berstad A. Tefera S, et al. Among authors: hatlebakk jg. Dig Dis Sci. 2001 Mar;46(3):618-25. doi: 10.1023/a:1005619803917. Dig Dis Sci. 2001. PMID: 11318542

8

Controversies in dyspepsia.

Berstad A, Olafsson S, Tefera S, Hatlebakk JG, Gilja OH, Hausken T. Berstad A, et al. Among authors: hatlebakk jg. Eur J Surg Suppl. 2001;(586):4-11. Eur J Surg Suppl. 2001. PMID: 11718524 Review.

9

Intragastric maldistribution of a liquid meal in patients with reflux oesophagitis assessed by three dimensional ultrasonography.

Tefera S, Gilja OH, Olafsdottir E, Hausken T, Hatlebakk JG, Berstad A. Tefera S, et al. Among authors: hatlebakk jg. Gut. 2002 Feb;50(2):153-8. doi: 10.1136/gut.50.2.153. Gut. 2002. PMID: 11788552 Free PMC article. Clinical Trial.

10

Diagnostic approach to suspected irritable bowel syndrome.

Hatlebakk JG, Hatlebakk MV. Hatlebakk JG, et al. Among authors: hatlebakk mv. Best Pract Res Clin Gastroenterol. 2004 Aug;18(4):735-46. doi: 10.1016/j.bpg.2004.04.001. Best Pract Res Clin Gastroenterol. 2004. PMID: 15324711 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page